Searched for
VACCINES DIVISION
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...
- 'I am not ashamed': Billionaire Harsh Goenka shares powerful note on what it means to be an Indian in a divided worldBillionaire Harsh Goenka's X post challenges global stereotypes about Indians, highlighting how narrow perceptions reduce rich cultures to ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- WHO states strike deal to extend talks on pandemic treatyWorld Health Organization member states will continue talks on a pandemic treaty for another year. Discussions focus on sharing access to d...
- FDA attributes 10 children's deaths to COVID vaccinesThe head of the FDA’s vaccine division said in an internal memo that at least 10 children died “after and because of” receiving a COVID vac...
- One of the world’s largest biotech firms, CSL to cut 3,000 Jobs and spin off its vaccine unitCSL Limited is set to demerge its influenza vaccine division, CSL Seqirus, into a separate ASX-listed entity by the end of fiscal year 2026...
- Zydus Cadila's shot to be soon part of vaccine driveTo begin with, seven states including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal will use the vaccine.
- 150,000 Covishield doses help J&K resume vaccinationsJammu and Kashmir received a fresh batch of 150,000 Covishield vaccine doses, helping resume the vaccination drive across the Union Territo...
- J&J seeks permission for phase-3 trial of its single-shot COVID vaccine in India, import licenceThis comes close to the heels of the central government last week deciding to fast-track emergency approvals for all foreign produced coron...
- Bharat Biotech set to dispatch first consignment of Covaxin"Today in the evening the first consignment is going out of Hyderabad.... (it is from ) Bharat Biotech. It is going to 11 destinations," an...
- PLUSS to supply temperature control boxes to SpiceJet for COVID-19 vaccine transportationAs part of a Memorandum of Understanding (MoU) signed between the two partners, PLUSS will supply its patented product, Celsure, for transp...
- Sanofi Pasteur launches injectable inactivated polio vaccineSanofi Pasteur, the vaccines division of Sanofi, today announced launch of ShanIPV, an injectable inactivated polio vaccine (IPV).
- New microneedle patch for measles vaccination designedThe underside of the patch is lined with 100 solid, conical microneedles made of polymer, sugar, and vaccine that are a fraction of a milli...
- Competition Commission of India clears Novartis-GlaxoSmithKline pharma dealThe multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...
- GlaxoSmithKline Biologicals in talks to buy BE's vaccine divisionThis division produces and markets a range of paediatric and adult vaccines and has a sizeable market share in the Indian vaccine market.
- Shantha bags over Rs 1,600 crore order from UnicefHyderabad-based Shantha Biotechnics has bagged a USD 340 million (around Rs 1,650 crore) order from Unicef to supply its 'SHAN5', a combina...
- Sanofi buys 80pc stake in Shantha Biotechnics for Rs 3,000 crFrench pharma major Sanofi-aventis today said its vaccine division Sanofi Pasteur has acquired 80 per cent stake in Shantha Biotechnics for...
Load More
